To study the mechanism of action of anetumab ravtansine, OVCAR-3 human ovarian cancer cells endogenously expressing mesothelin were incubated with 100 nM anetumab ravtansine for 4, 16, 24 or 48 h and the expression level of mesothelin was detected by Western blot. Here, MSLN is linked to ovarian carcinoma.